Metropolitan Life Insurance CO Arrowhead Pharmaceuticals, Inc. Transaction History

Metropolitan Life Insurance CO

$281 Million
Q3 2024

49 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$27.21 - $39.48 $5,278 - $7,659	194 Added 3.28%	6,101 $174,000
Q3 2023 Nov 14, 2023	BUY	$26.2 - $36.08 $5,161 - $7,107	197 Added 3.45%	5,907 $158,000
Q1 2023 May 15, 2023	SELL	$23.68 - $38.51 $15,320 - $24,915	-647 Reduced 10.18%	5,710 $145,000
Q4 2022 Jun 14, 2023	BUY	$28.0 - $40.56 $18,116 - $26,242	647 Added 11.33%	6,357 $258 Million
Q3 2022 Jun 14, 2023	BUY	$29.63 - $48.31 $19,170 - $31,256	647 Added 11.33%	6,357 $210 Million
Q2 2022 Jun 20, 2023	BUY	$27.79 - $50.61 $17,980 - $32,744	647 Added 11.33%	6,357 $223,000
Q1 2022 Jun 20, 2023	BUY	$39.62 - $69.97 $25,634 - $45,270	647 Added 11.33%	6,357 $292,000
Q1 2022 Mar 30, 2023	SELL	$39.62 - $69.97 $1.43 Million - $2.52 Million	-36,050 Reduced 85.01%	6,357 $292,000
Q1 2022 May 12, 2022	SELL	$39.62 - $69.97 $1.43 Million - $2.52 Million	-36,050 Reduced 85.01%	6,357 $292,000
Q4 2021 Jun 21, 2023	BUY	$58.09 - $82.51 $2.13 Million - $3.03 Million	36,697 Added 642.68%	42,407 $2.81 Million
Q4 2021 Mar 30, 2023	SELL	$58.09 - $82.51 $63,492 - $90,183	-1,093 Reduced 2.51%	42,407 $2.81 Million
Q4 2021 Feb 15, 2022	SELL	$58.09 - $82.51 $63,492 - $90,183	-1,093 Reduced 2.51%	42,407 $2.81 Million
Q3 2021 Jun 21, 2023	BUY	$58.38 - $84.96 $2.21 Million - $3.21 Million	37,790 Added 661.82%	43,500 $2.72 Million
Q3 2021 Mar 30, 2023	SELL	$58.38 - $84.96 $85,409 - $124,296	-1,463 Reduced 3.25%	43,500 $2.72 Million
Q3 2021 Nov 15, 2021	SELL	$58.38 - $84.96 $85,409 - $124,296	-1,463 Reduced 3.25%	43,500 $2.72 Million
Q2 2021 Jun 21, 2023	BUY	$62.15 - $90.32 $2.44 Million - $3.55 Million	39,253 Added 687.44%	44,963 $3.72 Million
Q2 2021 Mar 30, 2023	BUY	$62.15 - $90.32 $43,194 - $62,772	695 Added 1.57%	44,963 $3.72 Million
Q2 2021 Aug 16, 2021	BUY	$62.15 - $90.32 $2.79 Million - $4.06 Million	44,919 Added 102088.64%	44,963 $3.72 Million
Q1 2021 Jun 26, 2023	BUY	$61.35 - $90.47 $2.37 Million - $3.49 Million	38,558 Added 675.27%	44,268 $2.94 Billion
Q1 2021 Mar 30, 2023	BUY	$61.35 - $90.47 $10,184 - $15,018	166 Added 0.38%	44,268 $2.94 Million
Q1 2021 May 14, 2021	SELL	$61.35 - $90.47 $2.7 Million - $3.99 Million	-44,058 Reduced 99.9%	44 $2.94 Million
Q4 2020 Jun 22, 2023	BUY	$43.82 - $85.37 $1.68 Million - $3.28 Million	38,392 Added 672.36%	44,102 $3.38 Million
Q4 2020 Mar 30, 2023	SELL	$43.82 - $85.37 $60,690 - $118,237	-1,385 Reduced 3.04%	44,102 $3.38 Million
Q4 2020 Feb 16, 2021	SELL	$43.82 - $85.37 $60,690 - $118,237	-1,385 Reduced 3.04%	44,102 $3.38 Million
Q3 2020 Jun 26, 2023	BUY	$33.21 - $51.27 $1.32 Million - $2.04 Million	39,777 Added 696.62%	45,487 $1.96 Million
Q3 2020 Mar 30, 2023	SELL	$33.21 - $51.27 $73,228 - $113,050	-2,205 Reduced 4.62%	45,487 $1.96 Million
Q3 2020 Nov 13, 2020	SELL	$33.21 - $51.27 $73,228 - $113,050	-2,205 Reduced 4.62%	45,487 $1.96 Million
Q2 2020 Jun 26, 2023	BUY	$26.12 - $43.27 $1.1 Million - $1.82 Million	41,982 Added 735.24%	47,692 $2.06 Million
Q2 2020 Mar 30, 2023	SELL	$26.12 - $43.27 $171,660 - $284,370	-6,572 Reduced 12.11%	47,692 $2.06 Million
Q2 2020 Aug 14, 2020	SELL	$26.12 - $43.27 $171,660 - $284,370	-6,572 Reduced 12.11%	47,692 $2.06 Million
Q1 2020 Jul 12, 2023	BUY	$20.56 - $63.12 $998,270 - $3.06 Million	48,554 Added 850.33%	54,264 $1.56 Million
Q1 2020 Mar 30, 2023	BUY	$20.56 - $63.12 $1,768 - $5,428	86 Added 0.16%	54,264 $1.56 Million
Q1 2020 May 15, 2020	BUY	$20.56 - $63.12 $1,768 - $5,428	86 Added 0.16%	54,264 $1.56 Million
Q4 2019 Jul 12, 2023	BUY	$28.14 - $73.01 $1.36 Million - $3.54 Million	48,468 Added 848.83%	54,178 $3.44 Million
Q4 2019 Mar 30, 2023	BUY	$28.14 - $73.01 $669,985 - $1.74 Million	23,809 Added 78.4%	54,178 $3.44 Million
Q4 2019 Feb 14, 2020	BUY	$28.14 - $73.01 $669,985 - $1.74 Million	23,809 Added 78.4%	54,178 $3.44 Million
Q3 2019 Jul 12, 2023	BUY	$26.26 - $34.86 $647,545 - $859,612	24,659 Added 431.86%	30,369 $855,000
Q3 2019 Mar 30, 2023	BUY	$26.26 - $34.86 $37,866 - $50,268	1,442 Added 4.98%	30,369 $855,000
Q3 2019 Nov 14, 2019	BUY	$26.26 - $34.86 $37,866 - $50,268	1,442 Added 4.98%	30,369 $856,000
Q2 2019 Jul 12, 2023	BUY	$17.43 - $28.82 $409,692 - $677,414	23,505 Added 411.65%	29,215 $774,000
Q1 2019 Jul 13, 2023	BUY	$12.05 - $20.18 $279,764 - $468,519	23,217 Added 406.6%	28,927 $530,000
Q1 2019 Mar 30, 2023	BUY	$12.05 - $20.18 $271,968 - $455,462	22,570 Added 355.04%	28,927 $530,000
Q1 2019 May 16, 2019	BUY	$12.05 - $20.18 $330,338 - $553,214	27,414 Added 1811.9%	28,927 $530,000
Q1 2019 May 15, 2019	SELL	$12.05 - $20.18 $330,338 - $553,214	-27,414 Reduced 94.77%	1,513 $148,000
Q4 2018 Jul 13, 2023	BUY	$10.74 - $19.7 $249,350 - $457,374	23,217 Added 406.6%	28,927 $359,000
Q4 2018 Feb 14, 2019	BUY	$10.74 - $19.7 $242,638 - $445,062	22,592 Added 356.62%	28,927 $359,000
Q3 2018 Jul 13, 2023	BUY	$14.0 - $20.3 $325,038 - $471,305	23,217 Added 406.6%	28,927 $555 Million
Q3 2018 Nov 14, 2018	SELL	$14.0 - $20.3 $316,288 - $458,617	-22,592 Reduced 78.1%	6,335 $121,000
Q2 2018 Aug 15, 2018	BUY	$6.37 - $14.02 $184,264 - $405,556	28,927 New	28,927 $0

Others Institutions Holding ARWR

# of Institutions

294

Shares Held

90.8M

Call Options Held

155K

Put Options Held

426K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.01B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account